We are live on ! Find out more
ACUR

Acura Pharmaceuticals
ACUR

Delisted

ACUR was delisted on the 22nd of February, 2017.

Back to rankings

1 hedge funds and large institutions have $783K invested in Acura Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

11% less capital invested

Capital invested by funds: $880K → $783K (-$97K)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
1
Essex Woodlands Management
Texas
$783K – – –

ACUR Hedge Fund Activity: Q4 2017 in Review

1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Acura Pharmaceuticals (ACUR) for Q4 2017, worth a combined $783K — down 11% from $880K a quarter earlier.

Fund positioning in ACUR was balanced in Q4 2017: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Acura Pharmaceuticals (ACUR) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $783K of Acura Pharmaceuticals stock for Q4 2017, down 11% quarter-over-quarter.
  • 0 funds opened new Acura Pharmaceuticals positions in Q4 2017 and 0 closed out.

Based on aggregated 13F filings for Q4 2017.